Insight Molecular Diagnostics Total Current Liabilities 2014-2025 | IMDX
Insight Molecular Diagnostics total current liabilities from 2014 to 2025. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
| Insight Molecular Diagnostics Annual Total Current Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $7 |
| 2023 | $7 |
| 2022 | $12 |
| 2021 | $14 |
| 2020 | $9 |
| 2019 | $4 |
| 2018 | $6 |
| 2017 | $4 |
| 2016 | $4 |
| 2015 | $2 |
| 2014 | $6 |
| 2013 | $5 |
| Insight Molecular Diagnostics Quarterly Total Current Liabilities (Millions of US $) |
|
|---|---|
| 2025-03-31 | $10 |
| 2024-12-31 | $7 |
| 2024-09-30 | $9 |
| 2024-06-30 | $7 |
| 2024-03-31 | $8 |
| 2023-12-31 | $7 |
| 2023-09-30 | $8 |
| 2023-06-30 | $8 |
| 2023-03-31 | $9 |
| 2022-12-31 | $12 |
| 2022-09-30 | $13 |
| 2022-06-30 | $14 |
| 2022-03-31 | $14 |
| 2021-12-31 | $14 |
| 2021-09-30 | $13 |
| 2021-06-30 | $20 |
| 2021-03-31 | $10 |
| 2020-12-31 | $9 |
| 2020-09-30 | $9 |
| 2020-06-30 | $7 |
| 2020-03-31 | $7 |
| 2019-12-31 | $4 |
| 2019-09-30 | $3 |
| 2019-06-30 | $4 |
| 2019-03-31 | $3 |
| 2018-12-31 | $6 |
| 2018-09-30 | $5 |
| 2018-06-30 | $4 |
| 2018-03-31 | $5 |
| 2017-12-31 | $4 |
| 2017-09-30 | $5 |
| 2017-06-30 | $5 |
| 2017-03-31 | $5 |
| 2016-12-31 | $4 |
| 2016-09-30 | $4 |
| 2016-06-30 | $3 |
| 2016-03-31 | $3 |
| 2015-12-31 | $2 |
| 2015-09-30 | |
| 2015-06-30 | |
| 2015-03-31 | |
| 2014-12-31 | $6 |
| 2013-12-31 | $5 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.080B | $0.002B |
| Insight Molecular Diagnostics Inc. is a pioneering diagnostics technology company. Insight Molecular Diagnostics Inc., formerly known as Oncocyte Corporation, is based in NASHVILLE, Tenn. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.644B | 58.07 |
| Doximity (DOCS) | United States | $11.655B | 53.96 |
| Hims & Hers Health (HIMS) | United States | $11.295B | 117.35 |
| Tempus AI (TEM) | United States | $9.675B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.275B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.775B | 58.99 |
| Hinge Health (HNGE) | United States | $3.572B | 0.00 |
| Privia Health (PRVA) | United States | $2.516B | 172.00 |
| Enovis (ENOV) | United States | $1.765B | 9.84 |
| Phreesia (PHR) | United States | $1.591B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.517B | 0.00 |
| 10x Genomics (TXG) | United States | $1.505B | 0.00 |
| Schrodinger (SDGR) | United States | $1.495B | 0.00 |
| Azenta (AZTA) | United States | $1.461B | 67.89 |
| Evolent Health (EVH) | United States | $1.335B | 113.70 |
| Omnicell (OMCL) | United States | $1.276B | 22.51 |
| Claritev (CTEV) | United States | $0.717B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.550B | 0.00 |
| Veradigm (MDRX) | United States | $0.536B | 0.00 |
| Standard BioTools (LAB) | United States | $0.463B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.435B | 0.00 |
| Talkspace (TALK) | United States | $0.420B | 125.50 |
| TruBridge (TBRG) | United States | $0.321B | 713.00 |
| Outset Medical (OM) | United States | $0.320B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.270B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.260B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.231B | 0.00 |
| CapsoVision (CV) | United States | $0.213B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.203B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.136B | 0.00 |
| American Well (AMWL) | United States | $0.125B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.120B | 0.00 |
| Pulmonx (LUNG) | United States | $0.109B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.103B | 0.00 |
| CareCloud (CCLD) | United States | $0.098B | 3.73 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.083B | 0.00 |
| 111 (YI) | China | $0.064B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.046B | 0.00 |
| HeartBeam (BEAT) | United States | $0.042B | 0.00 |
| Zhongchao (ZCMD) | China | $0.028B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |